James Bylund Repligen Corp (RGEN) insider trading activity

RGEN Quotes by TradingView

James Bylund is Chief Operating Officer of REPLIGEN CORP. Currently has a direct ownership of 20,591 shares of RGEN, which is worth approximately $2.97 Million. The most recent transaction as insider was on Apr 02, 2024, when has been sold 444 shares (Common Stock) at a price of $182.95 per share, resulting in proceeds of $81,229. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.6K
0% 3M change
17.21% 12M change
Total Value Held $2.97 Million

James Bylund Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 02 2024
SELL
Payment of exercise price or tax liability
$81,229 $182.95 p/Share
444 Reduced 2.11%
20,591 Common Stock
Mar 07 2024
SELL
Payment of exercise price or tax liability
$236,038 $195.72 p/Share
1,206 Reduced 5.42%
21,035 Common Stock
Mar 05 2024
SELL
Payment of exercise price or tax liability
$4,301 $195.52 p/Share
22 Reduced 0.1%
22,241 Common Stock
Mar 04 2024
SELL
Payment of exercise price or tax liability
$38,216 $193.99 p/Share
197 Reduced 0.88%
22,263 Common Stock
Mar 01 2024
SELL
Payment of exercise price or tax liability
$157,267 $191.79 p/Share
820 Reduced 3.53%
22,410 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
50 Added 0.22%
22,460 Common Stock
Feb 29 2024
BUY
Grant, award, or other acquisition
-
404 Added 1.71%
23,230 Common Stock
Feb 27 2024
BUY
Grant, award, or other acquisition
-
8,691 Added 27.58%
22,826 Common Stock
Feb 23 2024
SELL
Open market or private sale
$866,203 $198.08 p/Share
4,373 Reduced 23.63%
14,135 Common Stock
Feb 23 2024
BUY
Exercise of conversion of derivative security
$88,670 $94.33 p/Share
940 Added 4.83%
18,508 Common Stock
Apr 04 2023
SELL
Payment of exercise price or tax liability
$54,592 $163.45 p/Share
334 Reduced 1.87%
17,568 Common Stock
Mar 03 2023
SELL
Payment of exercise price or tax liability
$39,480 $188.0 p/Share
210 Reduced 1.16%
17,902 Common Stock
Mar 03 2023
BUY
Grant, award, or other acquisition
-
625 Added 3.34%
18,112 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
8,348 Added 32.31%
17,487 Common Stock
Feb 28 2023
SELL
Payment of exercise price or tax liability
$103,023 $173.44 p/Share
594 Reduced 6.1%
9,139 Common Stock
Aug 03 2022
SELL
Open market or private sale
$480,800 $240.4 p/Share
2,000 Reduced 17.05%
9,733 Common Stock
Aug 03 2022
BUY
Exercise of conversion of derivative security
$188,660 $94.33 p/Share
2,000 Added 14.56%
11,733 Common Stock
Apr 01 2022
SELL
Payment of exercise price or tax liability
$62,987 $188.02 p/Share
335 Reduced 3.33%
9,733 Common Stock
Feb 24 2022
SELL
Payment of exercise price or tax liability
$35,571 $189.21 p/Share
188 Reduced 1.83%
10,068 Common Stock
Feb 24 2022
BUY
Grant, award, or other acquisition
-
3,366 Added 24.71%
10,256 Common Stock
Feb 17 2022
SELL
Payment of exercise price or tax liability
$60,928 $182.42 p/Share
334 Reduced 4.62%
6,890 Common Stock
Feb 17 2022
BUY
Grant, award, or other acquisition
-
900 Added 11.08%
7,224 Common Stock
Apr 06 2021
SELL
Open market or private sale
$73,530 $204.25 p/Share
360 Reduced 5.39%
6,324 Common Stock
JB

James Bylund

Chief Operating Officer
Waltham, MA

Track Institutional and Insider Activities on RGEN

Follow REPLIGEN CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

News

Receive news related to REPLIGEN CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RGEN